Anakök, Ömer FarukKöse, Pınar2024-07-032024-07-032023Anakok, O. F., Kose, P., & Bayindirli, K. N. (2023). Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM. Cytotherapy, 25(6), S258.1465-32491477-2566https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171031/https://hdl.handle.net/20.500.12491/12238Background & Aim: The new UCOE models we have recently developed, tested on many cell groups (including mouse ES and human iPS cells) and human mAb recombinant production studies as well, shows a powerful resistance to DNA methylation- mediated silencing and provides a higher and stable transfection profile. By the urgent need of vaccine development for COVID-19 during the pandemic, in this study we aimed to produce a potential recombinant vaccine by using the new generation UCOEs models of our own designeninfo:eu-repo/semantics/closedAccessSARS-CoV-2UCOERecombinant VaccineConference Object256S258S259WOS:001041036100524Q1